Switching from tablets or capsules to gummy vitamins looks like a simple upgrade until you get into the manufacturing details. From a production standpoint, you're not just changing the shape of a supplement. You're moving from a dry, mechanically controlled dosage form to a heat-processed, moisture-active system where texture, stability, and packaging can make or break the product.
The hardest thing to get used to is that a great gummy is a carefully engineered matrix, not a tablet that tastes good. And the most overlooked tension in gummy development is what we call the texture-assay tradeoff: the same decisions that create a soft, elastic, enjoyable chew can work against long-term consistency, especially across real-world storage conditions. Assay here means the measured potency of the active ingredient in the finished piece. A softer chew depends on higher moisture and humectant levels, and higher moisture accelerates degradation of water-sensitive actives. A formula that tests well on day one can fall short of label claim months later.
Why gummies behave nothing like tablets
Tablets and capsules are built around powder control: blend uniformity, flow, compression settings, and mechanical strength. Gummies are different. They're closer to a controlled confection process, with a finished product that's still “alive” in the sense that it can gain or lose moisture, shift texture, and react to packaging conditions over time.
In practical terms, the main risks change when you transition to gummies:
- Water activity (aw) and moisture become core quality drivers
- Thermal exposure during cooking/holding can reduce consistency if not controlled
- Viscosity and mixing determine whether each piece matches the label targets
- Stickiness, blocking, and texture drift become real shelf-life considerations
- Packaging becomes part of the formulation rather than an afterthought
The hidden constraint most “pill-to-gummy” guides miss
A lot of teams get tripped up by this: gummies have a limit on how much “stuff” you can load into each piece before you sacrifice chew, taste, or manufacturing control. Tablets can carry high dose levels in a compact form. Gummies have to balance dose with texture, flavor, and processability.
That's why a direct, 1:1 conversion from a pill formula often runs into a wall. Common outcomes of a realistic gummy redesign include:
- Reducing the total active load per serving
- Increasing serving size to 2-4 gummies instead of one pill
- Selecting ingredient forms that suspend and blend more consistently in a gummy mass
- Building flavor-masking into the formula early (instead of trying to “fix it later”)
In manufacturing terms, dose density is a feasibility checkpoint, not a marketing detail.
Choosing the right gummy base (and why it changes everything)
Not all gummies run the same way on a production floor. The base system determines your processing window, setting behavior, and stability profile. It also dictates which ingredients are easier or harder to incorporate without defects.
Gelatin-based systems
Gelatin gummies are known for that classic chew and elastic “bounce.” They can be forgiving once dialed in, but they're sensitive to moisture migration over time, and thermal history matters more than most people expect.
Pectin-based systems
Pectin systems are often chosen for plant-forward positioning and can produce a clean bite when properly tuned. The tradeoff is tighter process discipline: pH, soluble solids (Brix), timing, and set conditions must stay within a narrow lane to keep texture consistent.
Starch-based or hybrid systems
These systems can deliver specific textures and support certain stability goals, but they typically bring additional process complexity, especially around drying/curing and controlling variability across scale.
Formulation changes you can't ignore
The quickest way to struggle with gummies is to treat them like “tablets plus flavor.” Gummies require different specifications, different controls, and often a different approach to ingredient behavior.
Water activity is a real specification, not a nice-to-have
Gummies are shelf-stable largely because water activity (aw) is managed. Moisture percentage alone is not enough. Two products can share similar moisture numbers but behave very differently if aw is off, especially for texture and microbial risk control.
Acids and flavors influence structure
Acid systems affect more than taste. They can influence set behavior and texture and can increase the likelihood of tackiness when the overall balance isn't right. This matters even more in pectin systems where pH control is closely tied to performance.
Grittiness is a particle and dispersion problem
If you've ever bitten into a gummy and noticed a sandy texture, that's often a sign of particle size and dispersion strategy, not “bad flavor.” In a viscous gummy mass, suspension and mixing behavior can quickly expose weaknesses in raw material specs or mixing order.
The thermal budget: the silent driver of consistency
Unlike tablets, gummies are cooked and held before depositing. That means you're managing a thermal budget, the cumulative heat and time exposure across the run. Small changes in hold time, temperature, or addition timing can create larger-than-expected shifts in batch performance.
One of the most common fixes is process design, not a change of ingredients:
- Add sensitive components during a controlled cool-down phase
- Minimize hold time between final mixing and depositing
- Validate that mixing is still effective at lower temperatures (where viscosity rises)
Uniformity in gummies is not the same as tablet uniformity
Tablets can drift due to powder segregation and compression variables. Gummies drift differently, because you're mixing a thick mass, ingredients can settle or float, and depositor performance directly controls piece-to-piece output.
To manage this properly, gummy manufacturing leans on:
- Defined mixing parameters (time, RPM, temperature, viscosity targets)
- In-process checks for shot weight and piece weight
- Sampling plans that represent time and depositor lanes (not just one “grab sample”)
- Finished testing that confirms the batch is consistent and repeatable
Shelf life is packaging-driven (and that's not optional)
For gummies, packaging is part of the formulation. The same gummy can stay perfect for months, or it can turn tacky, hard, or crystallized, depending on barrier performance and moisture control.
Common field issues that stem from moisture migration and packaging mismatch include:
- Hardening from moisture loss
- Blocking (gummies sticking together)
- Surface crystallization that changes mouthfeel
- Sweating/tackiness in warm or humid conditions
This is why KorNutra approaches packaging selection early, alongside formulation and process, rather than treating it as a final design step.
Quality control: what a gummy needs to prove
A strong gummy QC program ties together chemical, physical, and in-process controls so the product you release is the product consumers experience months later.
- Identity and potency: incoming material checks and finished product verification
- Physical: piece weight variation, texture metrics, visual defect standards
- Chemical: moisture, water activity (aw), and pH (especially important for pectin)
- Micro: appropriate microbial testing plus sanitation and environmental controls consistent with cGMP expectations
A practical roadmap for a clean transition
If you want the move from pills to gummies to go smoothly, treat it like a controlled redevelopment, not a simple format swap. A typical, de-risked path looks like this:
- Feasibility screening: confirm dose density realism, compatibility, and target texture goals
- Bench and pilot development: map the thermal budget, set aw/moisture/pH targets, and establish depositing limits
- Prototype iteration: track the texture-assay tradeoff and tighten process parameters
- Stability planning: test under temperature and humidity stress, monitor texture drift and blocking
- Scale-up controls: lock in in-process checks, hold-time limits, and lane-to-lane consistency verification
The cost side of the conversion
A pill-to-gummy conversion changes the economics, not just the formula. Formulation development for a new gummy formula gets quoted between $2,000 and $15,000, and stability testing runs $3,000 to $8,000 per program. Custom mold tooling adds another up-front line item, and gummy production carries a higher per-bottle cost than capsules or tablets because of specialized equipment and longer cure times.
Two cost drivers catch teams off guard in early scoping. The first is overage. Gummies are a high-moisture, often acidic matrix where water-sensitive actives degrade faster than they do in a dry tablet, so manufacturers routinely build in 20% to 50% more active than the label states to hold potency above claim through shelf life. That extra active is a direct ingredient cost on every batch, and it grows as the dose you try to load goes up. The second is testing. Gummy QC adds moisture, water activity, and texture measurements to the standard identity, potency, micro, and heavy metals panel, and each additional method can add $200 to $800 per batch.
A gummy can still be the right product. The point is to price overage, testing load, and packaging barrier during feasibility screening, before the first production quote lands.
What to take away
The most successful gummy transitions happen when teams accept one simple reality: gummies are a different manufacturing discipline. When you design around water activity, thermal budget, uniformity in a viscous mass, and packaging, you can build a gummy that's consistent, scalable, and shelf-stable in the real world, not just on day one.
If you're planning a pill-to-gummy project and want to pressure-test the concept early, KorNutra can help you evaluate dose density, base system options, process constraints, packaging needs, and QC requirements before you spend cycles chasing preventable issues.